Patient-derived iPS cells for modeling and correction of inborn errors of immunity. Where do we stand?

Luigi D. Notarangelo, MD
Director, Research and Molecular Diagnosis Program, Professor of Pediatrics and Pathology, Harvard Medical School, Boston, MA
Monday, May 13, 2013 - 5:00pm
MSB 7231
Dr. Juan Carlos Zúñiga-Pflücker
Toronto Human Immunology Network, Panel Discussions in Human Immunology